Open AccessSensor-Controlled Scalp Cooling to Prevent Chemotherapy-Induced Alopecia in Female Cancer Patients
Author(s) -
Mathias K. Fehr,
JoEllen Welter,
Wieland Sell,
R. Jung,
R. Felberbaum
Publication year - 2016
Publication title -
current oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.053
H-Index - 51
eISSN - 1718-7729
pISSN - 1198-0052
DOI - 10.3747/co.23.3200
Subject(s) - medicine , docetaxel , epirubicin , carboplatin , chemotherapy , cyclophosphamide , tolerability , hair loss , breast cancer , scalp , paclitaxel , surgery , oncology , cancer , dermatology , adverse effect , cisplatin
Scalp cooling has been used since the 1970s to prevent chemotherapy-induced alopecia, one of the most common and psychologically troubling side effects of chemotherapy. Currently available scalp cooling systems demonstrate varying results in terms of effectiveness and tolerability.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom